• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
RACGP responds to aged care medication reform

RACGP responds to aged care medication reform

While generally supportive of the performance outcomes and role of onsite pharmacists, the college says gaps remain in the framework.


Global diabetes cases to reach 1.3 billion by 2050: Study

Global diabetes cases to reach 1.3 billion by 2050: Study

There are countries where as many as one in five people could be living with diabetes if current trends continue.


GlucaGen Hypokit in short supply until October

GlucaGen Hypokit in short supply until October

Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.


How should GPs discuss weight with their patients?

How should GPs discuss weight with their patients?

A high-profile body image advocate wants doctors to stop raising the issue, but clinicians say there are ways to sensitively approach the topic.


Pharmacy green light for insulin swap due to shortage

Pharmacy green light for insulin swap due to shortage

Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.


GPs key for equitable access to glucose monitors: RACGP

GPs key for equitable access to glucose monitors: RACGP

An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.


‘A major public health crisis’: Diabetes policy under scrutiny

‘A major public health crisis’: Diabetes policy under scrutiny

Could a new Parliamentary Inquiry help address gaps in knowledge about the disease, as well as improve policy?


Lower birthweight an independent risk factor for T2D: Study

Lower birthweight an independent risk factor for T2D: Study

It is also linked to diagnosis at a younger age, a lower prevalence of overweight/obesity, and fewer family members with a history of diabetes.


RACGP opposes GLP-1 RA prescribing restrictions

RACGP opposes GLP-1 RA prescribing restrictions

Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.


GLP-1 RA prescribing checks flagged

GLP-1 RA prescribing checks flagged

GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.


  • Previous
  • ...
  • 10
  • 11
  • 12
  • ...
  • Next
Pages: 10 of 26
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807